A Study to Evaluate the Effects of Mavacamten in Healthy Participants

Part of paid clinical trials in Miami, Florida.

Sponsor
Bristol-Myers Squibb
Study ID
NCT05719805
Phase
PHASE1
Status
Completed

Conditions

  • Healthy Participants

Eligibility Criteria

Sex
ALL
Age
18 Years - 60 Years
Healthy Volunteers
Accepted

Interventions

  • Mavacamten — DRUG
    Specified dose on specified days

Study Details

The purpose of the study is to evaluate the effect between two different single doses of mavamten in healthy participants.

Key Dates

Start date
Feb 20, 2023
Status verified
Oct 2023
Primary completion
Jul 25, 2023
Completion
Jul 25, 2023

Study Design

Enrollment
84 participants (actual)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Mavacamten Dose 1
  • Experimental: Mavacamten Dose 2

Primary Outcome Measure

Maximum observed plasma concentration (Cmax) [ Time Frame: Predose and post-dose up to Day 80 ]

Locations (2)

FacilityCityStateZIPSite coordinators
Local Institution - 0001MiamiFlorida33136-
Local Institution - 0002Saint PaulMinnesota55114-

Find similar trials in Miami, FL

By research site
Local Institution - 0001· Miami, FLLocal Institution - 0002· Saint Paul, MN

Related Studies